Vital News About Diabetes Drug Avandia - Possible Heart Attack Risk
Harmed by Avandia? You can get a free case review and learn more about the health risks associated with this Type 2 diabetes medication here.
November 14, 2007--Second Black Box Warning
Due to the risk of
heart attack, the Food and Drug Administration has issued its strictest
warning on Avandia.
The Food and Drug Administration (FDA) announced that the manufacturer of
Avandia (rosiglitazone), GlaxoSmithKline, has agreed to add information to the
existing boxed warning on the drug's label about possible increased heart attack
risk. The drug is also marketed as Avandamet
and Avandaryl.
In
May 2007, an analysis of over
40 clinical studies raised concerns about the potential cardiovascular
complications associated with taking Avandia.
Researchers found that
Avandia significantly increases the potential for heart attacks in patients as
compared with other diabetes medications or a placebo.
The Food and Drug
Administration has issued a warning to users of the medicine, recommending
they discuss with their doctors the health concerns that come with taking
Avandia.
If you or a loved one has suffered cardiac complications after
ingesting Avandia, you deserve the guidance of a knowledgeable drug attorney.
Get a free case review by filling out the form below.
see also:
Firm's Press Release
Weitz & Luxenberg Lawyers Respond to Study Casting Doubt on AvandiaW&L Lawyers React to Growing Scientific Evidence Against Avandia
Research Center
Learn the Health Risks Associated With Avandia: Get Lawsuit ResourcesConsidering an Avandia Lawsuit? Research Health Risks, Side Effects
Medtronic Sprint Fidelis Leads
Dangerous Faulty Wires Prompt Medtronic Sprint Recall--Get Legal InfoMalfunctioning Medtronic Sprint Fidelis leads? Learn about the recall.
